Ming Yan - Nov 18, 2023 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Signature
/s/ Valerie Barnett, Attorney-in-Fact for Ming Yan
Stock symbol
CTKB
Transactions as of
Nov 18, 2023
Transactions value $
-$139,754
Form type
4
Date filed
11/21/2023, 05:59 PM
Previous filing
Nov 27, 2023
Next filing
Dec 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise +1.98K +0.03% 7.78M Nov 18, 2023 Direct F1
transaction CTKB Common Stock Tax liability -$4.62K -772 -0.01% $5.98 7.78M Nov 18, 2023 Direct F2
transaction CTKB Common Stock Options Exercise +7.36K +0.09% 7.78M Nov 18, 2023 Direct F1
transaction CTKB Common Stock Tax liability -$14.5K -2.43K -0.03% $5.98 7.78M Nov 18, 2023 Direct F2
transaction CTKB Common Stock Sale -$121K -20K -0.26% $6.03 7.76M Nov 20, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Options Exercise $0 -1.98K -10.34% $0.00 17.2K Nov 18, 2023 Common Stock 1.98K Direct F1, F5
transaction CTKB Restricted Stock Units Options Exercise $0 -7.36K -6.98% $0.00 98.2K Nov 18, 2023 Common Stock 7.36K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.88 to $6.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
F6 The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.